GDF15 and COVID-19: The underlying mechanism for increasing GDF15 serum level in COVID-19 patients with GIT injury and/or acute hepatic damage is due to hyperinflammation, oxidative stress and exaggeration of inflammatory signaling pathways [48,51,53].